MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials.

MAX2--a convenient index to estimate the average per patient risk for chemotherapy toxicity; validation in ECOG trials. Eur J Cancer. 2004 May; 40(8):1193-8.

View in: PubMed

subject areas

Adult
Age Factors
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Health Status Indicators
Humans
Middle Aged
Neoplasms
Regression Analysis
Risk Factors
Sensitivity and Specificity

authors with profiles

Philip Bonomi